The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127160012 12716001 2 F 20160429 20160824 20160906 20160906 EXP PHHY2016GR117018 NOVARTIS 5.70 YR M Y 0.00000 20160906 CN GR GR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127160012 12716001 1 PS CICLOSPORIN CYCLOSPORINE 1 Unknown 4 MG/KG, UNK (FROM DAY 1) U 50574 4 MG/KG
127160012 12716001 2 SS ARACYTIN CYTARABINE 1 Unknown 0 SOLUTION FOR INJECTION
127160012 12716001 3 SS IDARUBICIN HCL IDARUBICIN HYDROCHLORIDE 1 Unknown U 0
127160012 12716001 4 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Unknown 1000 MG/M2 (1 GR/M2), UNK U 0 1000 MG/M**2
127160012 12716001 5 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Unknown 3.10 MG/M2, UNK (DAY +1 AND +3) U 0 3.1 MG/M**2
127160012 12716001 6 SS CLOFARABINE CLOFARABINE 1 Unknown U 0
127160012 12716001 7 SS ETOPOSIDE. ETOPOSIDE 1 Unknown U 0
127160012 12716001 8 SS ENDOXAN CYCLOPHOSPHAMIDE 1 Unknown U 0
127160012 12716001 9 SS ERWINASE//ASPARAGINASE ASPARAGINASE ERWINIA CHRYSANTHEMI 1 Unknown 0
127160012 12716001 10 SS ONCOVIN VINCRISTINE SULFATE 1 Unknown 0
127160012 12716001 11 SS DEXAMETHASONE. DEXAMETHASONE 1 Unknown 0
127160012 12716001 12 SS FLUDARA FLUDARABINE PHOSPHATE 1 Unknown 30 MG/KG, (1 X 5 DAYS) U 0 30 MG/KG
127160012 12716001 13 SS BUSILVEX BUSULFAN 1 Unknown 1.1 MG/KG, UNK (16 DOSES) U 0 1.1 MG/KG
127160012 12716001 14 SS THIOTEPA. THIOTEPA 1 Unknown 5 MG/KG, (X 2 X 1 DAY) U 0 5 MG/KG
127160012 12716001 15 SS ATG//ANTITHYMOCYTE IMMUNOGLOBULIN LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN 1 Unknown 7.5 MG/KG, UNK (TOTAL DOSE) U 0 7.5 MG/KG
127160012 12716001 16 SS FLUDARABIN FLUDARABINE PHOSPHATE 1 Unknown U 0
127160012 12716001 17 SS 6-MERCAPTOPURINE MONOHYDRATE MERCAPTOPURINE 1 Unknown UNK UNK, QD U 0 QD
127160012 12716001 18 SS ASPARAGINASE MEDAC ASPARAGINASE 1 Unknown U 0
127160012 12716001 19 SS ONCASPAR PEGASPARGASE 1 Unknown U 0
127160012 12716001 20 SS TARGOCID TEICOPLANIN 1 Unknown U 0
127160012 12716001 21 SS PREDNISONE. PREDNISONE 1 Unknown U 0
127160012 12716001 22 SS DOXORUBICIN DOXORUBICIN 1 Unknown UNK U 0
127160012 12716001 23 SS ASPARAGINASE ASPARAGINASE 1 Unknown UNK U 0
127160012 12716001 24 SS VINCRISTINE VINCRISTINE 1 Unknown UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127160012 12716001 1 Graft versus host disease
127160012 12716001 2 Acute lymphocytic leukaemia
127160012 12716001 3 Acute lymphocytic leukaemia
127160012 12716001 4 Acute lymphocytic leukaemia
127160012 12716001 6 Acute lymphocytic leukaemia
127160012 12716001 7 Acute lymphocytic leukaemia
127160012 12716001 8 Acute lymphocytic leukaemia
127160012 12716001 9 Product used for unknown indication
127160012 12716001 10 Acute lymphocytic leukaemia
127160012 12716001 11 Acute lymphocytic leukaemia
127160012 12716001 12 Acute lymphocytic leukaemia
127160012 12716001 13 Acute lymphocytic leukaemia
127160012 12716001 14 Acute lymphocytic leukaemia
127160012 12716001 15 Acute lymphocytic leukaemia
127160012 12716001 16 Acute lymphocytic leukaemia
127160012 12716001 17 Acute lymphocytic leukaemia
127160012 12716001 18 Acute lymphocytic leukaemia
127160012 12716001 19 Acute lymphocytic leukaemia
127160012 12716001 20 Acute lymphocytic leukaemia
127160012 12716001 21 Acute lymphocytic leukaemia
127160012 12716001 22 Acute lymphocytic leukaemia
127160012 12716001 23 Acute lymphocytic leukaemia
127160012 12716001 24 Acute lymphocytic leukaemia

Outcome of event

Event ID CASEID OUTC COD
127160012 12716001 HO
127160012 12716001 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127160012 12716001 Acute lymphocytic leukaemia recurrent
127160012 12716001 Bacterial sepsis
127160012 12716001 Bone marrow leukaemic cell infiltration
127160012 12716001 Epstein-Barr virus infection
127160012 12716001 Febrile neutropenia
127160012 12716001 Hepatosplenomegaly
127160012 12716001 Hypersensitivity
127160012 12716001 Platelet count increased
127160012 12716001 Pseudomonal sepsis
127160012 12716001 Serratia sepsis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127160012 12716001 17 20150310 0
127160012 12716001 22 20140612 0
127160012 12716001 23 20140612 0
127160012 12716001 24 20140612 0